Bloomage BioTechnology (SHSE:688363) Total Stockholders Equity : ¥6,929 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology Total Stockholders Equity?

Bloomage BioTechnology's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥6,929 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bloomage BioTechnology's Book Value per Share for the quarter that ended in Mar. 2025 was ¥14.38. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bloomage BioTechnology's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.06.

Bloomage BioTechnology Total Stockholders Equity Historical Data

The historical data trend for Bloomage BioTechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomage BioTechnology Total Stockholders Equity Chart

Bloomage BioTechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

5,019.76

5,699.01

6,633.78

6,944.10

6,810.17

Bloomage BioTechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															7,087.99	6,985.66	7,018.77	6,810.17	6,928.89

Bloomage BioTechnology (SHSE:688363) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bloomage BioTechnology's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6928.894	-	0)	/	481.678
	=	14.38

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bloomage BioTechnology's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(207.739	+	202.702)	/	6928.894
	=	0.06

Bloomage BioTechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomage BioTechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN

Website

http://www.bloomagebio-tech.com

Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.

Executives

Zhao Yi	Core technical personnel
Luan Yi Hong	Core technical personnel
Shi Yan Li	Core technical personnel
Liu Jian Jian	Core technical personnel
Wang Yu Ling	Core technical personnel
Zhou Wei	Core technical personnel
Huang Si Ling	Core technical personnel
Han Hong Ling	Core technical personnel
Lu Zhen	Core technical personnel

Bloomage BioTechnology Headlines

No Headlines